The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 3, 2014, Pages 516-523

  Hanouneh, Ibrahim A ^a   Zein, Nizar N ^a   Cikach, Frank ^a   Dababneh, Luma ^a   Grove, David ^a   Alkhouri, Naim ^a   Lopez, Rocio ^a   Dweik, Raed A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Alcohol consumption; Liver damage; Marker panel; Microbiota

Indexed keywords

ALCOHOL CONSUMPTION; LIVER DAMAGE; MARKER PANEL; MICROBIOTA;

ADULT; AGED; BIOLOGICAL MARKERS; BREATH TESTS; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; VOLATILE ORGANIC COMPOUNDS;

EID: 84893951343     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.08.048     Document Type: Article

References (20)

1. Manning D.S., Afdhal N.H. Diagnosis and quantitation of fibrosis. Gastroenterology 2008, 134:1670-1681.
2. Poniachik J., Bernstein D.E., Reddy K.R., et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996, 43:568-571.
3. Paschke K.M., Mashir A., Dweik R.A. Clinical applications of breath testing. F1000 Med Rep 2010, 22:56.
4. Ross B.M. Sub-parts per billion detection of trace volatile chemicals in human breath using selected ion flow tube mass spectrometry. BMC Res Notes 2008, 1:41.
5. Klatt S., Taut C., Mayer D., et al. Evaluation of the C-methacetin breath test for quantitative liver function testing. Zeitschrift fur Gastroenterologie 1997, 35:609-614.
6. Wang Z., Klipfell E., Bennett B.J., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
7. Zhang A.Q., Mitchell S.C., Smith R.L. Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol 1999, 37:515-520.
8. Guarner C., Runyon B.A., Young S., et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. JHepatol 1997, 26:1372-1378.
9. Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 2009, 50:638-644.
10. Lucey M.R., Mathurin P., Morgan T.R. Alcoholic hepatitis. NEngl J Med 2009, 360:2758-2769.
11. Prince B.J., Milligan D.B., McEwan M.J. Application of selected ion flow tube mass spectrometry to real-time atmospheric monitoring. Rapid Commun Mass Spectrom 2010, 24:1763-1769.
12. Smith D., Spanel P. Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. Mass Spectrom Rev 2005, 24:661-700.
13. Mathurin P., Poynard T., Ramond M.J., et al. Interet de la biopsie hepatique pour la sélection des sujets suspects d'hepatitealcoolique aigue. Gastroenterol Clin Biol 1992, 16:A231.
14. Wranne L. Urinary excretion of trimethylamine and trimethylamine oxide following trimethylamine administration to normal and to patients with liver disease. Acta Medica Scand 1956, 153:6.
15. Mitchell S., Ayesh R., Barrett T., et al. Trimethylamine and foetor hepaticus. Scand J Gastroenterol 1999, 34:524-528.
16. Mitchell S.C., Smith R.L. Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos 2001, 29:517-521.
17. Zhou J., Shephard E.A. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3. Mutat Res 2006, 612:165-171.
18. Riely A., Cohen G., Lieberman M. Ethane evolution: a new index of lipid peroxidation. Science 1974, 183:208-210.
19. Meagher E.A., Barry O.P., Burke A., et al. Alcohol-induced generation of lipid peroxidation products in humans. JClin Invest 1999, 104:805-813.
20. Bailey S.M., Cunningham C.C. Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes. Hepatology 1998, 28:1318-1328.